Immuneering Corporation (IMRX) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$5.28
-8.33%
Mkt Cap $209.10M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 6, 2026 | — | — | — | -$0.31 | -$0.18 | +41.94% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.37 | -$0.38 | -2.70% | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | -$0.40 | -$0.40 | +0.00% | — | — |
| Q2 2025 May 5, 2025 | — | — | — | -$0.41 | -$0.42 | -2.44% | — | — |
| Q1 2025 Mar 20, 2025 | — | — | — | -$0.42 | -$0.58 | -38.10% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.54 | -$0.49 | +9.26% | — | — |
| Q3 2024 Aug 6, 2024 | — | — | — | -$0.51 | -$0.47 | +7.84% | — | — |
| Q2 2024 May 7, 2024 | — | — | — | -$0.45 | -$0.49 | -8.89% | — | — |
| Q1 2024 Mar 1, 2024 | — | -$94.42M | — | -$0.48 | -$0.52 | -8.33% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.51 | -$0.43 | +15.69% | — | — |
| Q3 2023 Aug 3, 2023 | — | $94.42M | — | -$0.54 | -$0.43 | +20.37% | — | — |
| Q2 2023 May 4, 2023 | $8.33K | — | — | -$0.54 | -$0.51 | +5.56% | — | — |
| Q1 2023 Mar 6, 2023 | $60.00K | $456 | -99.24% | -$0.58 | -$0.50 | +13.79% | — | — |
| Q4 2022 Nov 10, 2022 | $153.33K | $38.38K | -74.97% | -$0.48 | -$0.49 | -2.08% | — | — |
| Q3 2022 Aug 10, 2022 | $196.80K | $94.42K | -52.02% | -$0.52 | -$0.44 | +15.38% | — | — |
| Q2 2022 May 10, 2022 | $182.00K | $183.70K | +0.93% | -$0.44 | -$0.49 | -11.36% | — | — |
| Q1 2022 Mar 10, 2022 | $535.50K | $189.59K | -64.60% | -$0.39 | -$0.42 | -7.69% | — | — |
| Q4 2021 Nov 9, 2021 | $330.00K | $482.13K | +46.10% | -$0.61 | -$0.47 | +22.95% | — | — |
| Q3 2021 Sep 9, 2021 | — | $660.04K | — | -$1.44 | -$1.61 | -11.81% | — | — |
| Q3 2021 Jul 30, 2021 | — | $748.20K | — | — | -$0.46 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | $665.08K | — | — | -$0.43 | — | — | — |
| Q3 2020 Sep 30, 2020 | — | $682.57K | — | — | -$0.33 | — | — | — |
| Q2 2020 Jun 30, 2020 | — | $480.83K | — | — | -$0.27 | — | — | — |
| Q1 2020 Mar 31, 2020 | — | $483.05K | — | — | -$0.24 | — | — | — |